These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 15224960
1. The financial implications of coverage of smoking cessation treatment by managed care organizations. Warner KE, Mendez D, Smith DG. Inquiry; 2004; 41(1):57-69. PubMed ID: 15224960 [Abstract] [Full Text] [Related]
3. Costs, commitment and locality: a comparison of for-profit and not-for-profit health plans. Inquiry; 2004 Aug; 41(2):116-29. PubMed ID: 15449428 [Abstract] [Full Text] [Related]
4. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. Cromwell J, Bartosch WJ, Fiore MC, Hasselblad V, Baker T. JAMA; 1997 Dec 03; 278(21):1759-66. PubMed ID: 9388153 [Abstract] [Full Text] [Related]
5. Estimated Budget Impact of Adopting the Affordable Care Act's Required Smoking Cessation Coverage on United States Healthcare Payers. Baker CL, Ferrufino CP, Bruno M, Kowal S. Adv Ther; 2017 Jan 03; 34(1):156-170. PubMed ID: 27888437 [Abstract] [Full Text] [Related]
6. The SmokingPaST Framework: illustrating the impact of quit attempts, quit methods, and new smokers on smoking prevalence, years of life saved, medical costs saved, programming costs, cost effectiveness, and return on investment. O'Donnell MP, Roizen MF. Am J Health Promot; 2011 Jan 03; 26(1):e11-23. PubMed ID: 21879928 [Abstract] [Full Text] [Related]
8. Value for the money spent? Exploring the relationship between expenditures, insurance adequacy, and access to care for publicly insured children. Colby MS, Lipson DJ, Turchin SR. Matern Child Health J; 2012 Apr 03; 16 Suppl 1():S51-60. PubMed ID: 22476794 [Abstract] [Full Text] [Related]
9. The cost-effectiveness of the English smoking treatment services: evidence from practice. Godfrey C, Parrott S, Coleman T, Pound E. Addiction; 2005 Apr 03; 100 Suppl 2():70-83. PubMed ID: 15844290 [Abstract] [Full Text] [Related]
10. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece. Athanasakis K, Igoumenidis M, Karampli E, Vitsou E, Sykara G, Kyriopoulos J. Clin Ther; 2012 Aug 03; 34(8):1803-14. PubMed ID: 22818870 [Abstract] [Full Text] [Related]
13. Cost and effectiveness of the nationwide government-supported Smoking Cessation Clinics in the Republic of Korea. Oh JK, Lim MK, Yun EH, Shin SH, Park EY, Park EC. Tob Control; 2013 May 03; 22(e1):e73-7. PubMed ID: 22752272 [Abstract] [Full Text] [Related]
15. Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model. Lutz MA, Lovato P, Cuesta G. Hosp Pract (1995); 2012 Feb 03; 40(1):24-34. PubMed ID: 22406880 [Abstract] [Full Text] [Related]
18. Determining the cost-effectiveness of a computer-based smoking cessation intervention in primary care. Smith MY, Cromwell J, DePue J, Spring B, Redd W, Unrod M. Manag Care; 2007 Jul 03; 16(7):48-55. PubMed ID: 17907712 [Abstract] [Full Text] [Related]
19. Implementation of evidence-based tobacco use cessation guidelines in managed care organizations. Taylor CB, Curry SJ. Ann Behav Med; 2004 Feb 03; 27(1):13-21. PubMed ID: 14979859 [Abstract] [Full Text] [Related]